Japanese scientist Makoto Kobayashi smiles during a news conference in Tokyo after learning that he won the 2008 Nobel Prize for Physics for discoveries in sub-atomic particles. (REUTERS/Kyodo)
Asia trumping US on science R&D
Federal funding for research has been falling in real terms. Is the nation’s economic edge at stake?
By Peter N. Spotts | Staff Writer for The Christian Science Monitor/ October 9, 2008 edition
Reporter Peter N. Spotts talks about federal funding for scientific research drying up.
Reporter Peter N. Spotts
Washington
Tallying this year’s Nobel Prizes so far, it’s been a respectable year for US-based scientists. Four shared the prestigious awards – three for chemistry and one as part of an international trio for physics.
As congratulations pour in, however, some science-policy specialists in the United States see troubling signs that federal support for research – measured by checks written rather than checks promised – may be weakening.
To those involved in federally funded research, their work represents a kind of intellectual infrastructure that, if allowed to erode, can begin to undermine the country’s economic competitiveness.
The immediate concern is the continuing resolution the president signed Sept. 30. Congress punted final passage of the federal budget to next March. Except for the Defense Department, other federal agencies responsible for performing or funding research must hold spending at or below fiscal year 2008 levels.
These are trying fiscal times, acknowledges Pat White, vice president for federal relations at the Association of American Universities in Washington. Deficits and the federal debt are soaring. Unavoidable spending on programs such as Social Security, as well as interest on the federal debt is rising. And now the government is undertaking a $700 billion rescue package for the financial industry.
The budget’s math “is such that it’s going to be very hard to make any sort of dramatic new investments” in research, Mr. White says. “On the other hand, over the last five years we always find ourselves at the last minute fighting at the margins.” For instance, in fiscal year 2008, budget negotiations bogged down over $22 billion Congress added in nondefense discretionary spending, out of a $932 billion discretionary budget, he explains. The R&D portion of that $22 billion – at least among the government’s biggest R&D players – was about $3 billion. Either way, “that’s not a lot of money,” he says.
Beginning with fiscal year 2005, federal spending on research has fallen off after accounting for inflation. The decline may advance into fiscal year 2009 with an expected revision to inflation figures, according to a recent analysis by the American Association for the Advancement of Science (AAAS). The drop-off comes after a five-year sustained increase, driven largely by money Congress pumped into the National Institutes of Health (NIH).
The US spends more on R&D – including industrial R&D spending – than any other country on the planet. At $344 billion, the US accounts for roughly a third of global R&D spending. Japan comes in at No. 2, spending $139 billion. China, Japan, and South Korea combined account for 27 percent of the global total, outstripping the European Union’s investment.
Yet US R&D spending between 1991 and 2006 has hovered between 2.6 to 2.8 percent of gross domestic product. Japan and Korea, however, have increased their investments during that period to more than 3 percent of GDP. China has captured attention for its growth rate, rising from 1 to 1.4 percent of GDP in five years – the government’s typical economic planning horizon. It’s a growth rate that closely matches Korea’s over the same period. This spending gauge often is seen as a better indicator ,than raw spending numbers of a country’s commitment to R&D as an economic priority.
In the US, industry now appears far less likely to conduct basic research. The once-storied Bell Laboratories in Murray Hill, N.J., which spawned six Nobel Prizes, reportedly has all but shut down its work in basic physics. Its parent company, Alcatel-Lucent, has shifted resources to math, computer science, and wired and wireless networking research – more in line bottom-line products.
The continuing resolution’s effect on research, combined with recent funding trends, “is very hurtful,” says Steven Fluharty, vice president for research at the University of Pennsylvania in Philadelphia. For three years, researchers in the physical sciences have been promised more money through the American Competitiveness Initiative. “It reaches a point where funding agencies issue calls for research proposals, but then the money doesn’t come,” he says. “It wastes everybody’s time.”
It also sends lab leaders scrambling to bridge the gap in hopes that the new Congress will pass a new budget, and not focus exclusively on the fiscal year 2010 budget. That would in effect freeze spending at 2008 levels throughout 2009.
“We’re back in the soup here,” says Piermaria Oddone, director of the Fermi National Accelerator Laboratory in Batavia, Ill. For now, he says, he can bridge the gap through March. “But we don’t know what happens after that. It’s very difficult on the staff. They know we’re in deep trouble” if additional money doesn’t come through.
( More stories )
Comments
2. Student | 10.10.08
Innovation’s are two types as far as i know….
1. Design Based, which does not focus on market, like people publishing research papers for science.
2. Market Based innovation, which is like creating different product using blue ocean strategy, and market for the product, but to make it work, there has to be good science, because you simply cannot add a wishful feature, by removing something else, that creates a whole new product. ![]()
3. Annelies | 10.10.08
(And technically, Gates started out with someone else’s idea!)
The problem is short-term thinking. My iPod is a direct-line descendant of people noodling around doing basic research without a specific goal/product in sight: http://www.nytimes.com/2007/10/10/world/10nobel.html?fta=y
The whole idea of a society investing in the future has been degraded in the U.S.
4. Observer | 10.11.08
Bill Gates could start out with lesser dollars because MSDOS software is relatively simple and low cost to develop, but Bill Gates started out with $30 million in his trust fund so initially his entire personal risk was his time and a few dollars.
The U.S. research budgets are controlled by politicians and non-scientists who do not understand the research process or understand the need to remain vigilant in research over the long term, which is at the heart of the problem. They don’t “get it”. On the business side, the few MBAs running the show have deliberately trashed the credit markets, subsequently trashing the business climate, ensuring self enrichment at everyone else’s expense with impunity. Our leadership is wasting trillions of dollars on pork-barrel spending, bogus loans, gold plated toilets, and Freddie Mac and Fannie Mae end-of-the-world parties which will not advance science but will place substantial pressure on all budgets going forward. Expect deflation in the USA to continue, as the alternative is hyper-inflation.
China is well positioned to lead research funding for the next century. China is sitting on $1.5 trillion in US cash. Once the US market drops enough we will come in and buy up all of the good assets at fire sale prices which will include taking over control of some major research institutions. Learn Chinese.
Trackbacks/Pingbacks
Leave a Comment
We do not publish all comments, and we do not publish comments immediately. The comments feature is a forum to discuss the ideas in our stories. Constructive debate - even pointed disagreement - is welcome, but personal attacks on other commenters are not, and will not be published.
Tip: Do not write a novel. Keep it short. We will not publish lengthy comments. Come up with your own statements. This is not a place to cut and paste an email you received. If we recognize it as such, we won't post it.
Please do not post any comments that are commercial in nature or that violate copyrights.
Finally, we will not publish any comments that we regard as obscene, defamatory, or intended to incite violence.





1. Linnea | 10.10.08
With the current emphasis on “Market Research” (ie: How much of this product will actually sell, anyway?) and the influx of “Consulting” groups into Pharmaceutical Companies (ie: “How to Increase R & D Productivity With Less Money, Creativity, and Innovation”, by people who know NOTHING about science OR innovation, for that matter), as well as America’s current cautious approach to actually creating something NEW and taking risks in the Laboratory, it is highly unlikely that more money will make any difference anyway. No innovative product was ever invented without good science and risk-taking. By its very definition, science is a risky business, and no amount of money will ever eliminate the need for scientists who go out on a limb to develop products never seen before. Copying someone else’s product is not innovation, and adding something to someone else’s product is not innovation. Bill Gates started out with an idea, not a billion dollars.